Insomnia News and Research

Latest Insomnia News and Research

Over-the-counter sale of child cough medicine for young children to be banned

As from September this year the over-the-counter sale of cough medicines for children under the age of two years old will be banned in Australia.

9 Apr 2008

Aripiprazole has potential for treating alcohol dependence

Aripiprazole is currently approved to treat bipolar disorder as well as schizophrenia. A new study has found that it significantly and dose-dependently increases the sedative effects of alcohol and, to a lesser degree, decreases the euphoric effects of alcohol. Future research will need to examine the beneficial versus the side effects of aripiprazole for treatment of alcohol dependence.

4 Apr 2008

Link found between insomnia and depression in young adults

A study published in the April 1 issue of the journal SLEEP confirms the persistent nature of insomnia and the increased risk of subsequent depression among individuals with insomnia.

2 Apr 2008

Allergies dramatically impact sufferers' moods and how they feel about themselves

A new Harris Interactive phone survey conducted among 1,000 allergy sufferers, 1,000 consumers (both allergy sufferers and non-sufferers) and 300 physicians shows that beyond the sneezing, sniffling and watery eyes, allergies also have deep and emotional impacts on a sufferer's mood and self-perceptions.

24 Mar 2008

Where nurses are bullied, the quality of patient care declines

In workplaces where nurses are bullied, the quality of patient care declines, the health of nurses suffers, and the retention of quality nurses becomes difficult.

24 Mar 2008

Chronic insomnia and its negative consequences for adolescents

Documenting a "twofold to fivefold" increase in personal problems among adolescents with persistent sleeplessness, public health researchers at The University of Texas Health Science Center at Houston say they have completed the first prospective study demonstrating the negative impact of chronic insomnia on 11 to 17 year olds.

24 Mar 2008

Cortisol provide relief for chronic fatigue syndrome and fibromyalgia sufferers

Chronic fatigue syndrome (CFS) and fibromyalgia (FM) are two serious and debilitating diseases with no confirmed cause and limited treatment options.

20 Mar 2008

FDA approves PRISTIQ for the treatment of adult patients with major depressive disorder

Wyeth Pharmaceuticals, a division of Wyeth, has announced that the U.S. Food and Drug Administration (FDA) has approved PRISTIQ (desvenlafaxine), a structurally novel, once-daily serotonin-norepinephrine reuptake inhibitor (SNRI), to treat adult patients with major depressive disorder (MDD).

3 Mar 2008

A similarity in the meaning of sleep quality between insomniacs, normal sleepers

Both insomnia patients and normal sleepers define sleep quality by tiredness upon waking and throughout the day, feeling rested and restored upon waking, and the number of awakenings they experienced in the night.

3 Mar 2008

SSRI anti-depressants found to offer little clinical benefit

According to new research from Britain, new generation anti-depressants could be for many patients a waste of time and money and offer little clinical benefit.

26 Feb 2008

Effects of Kava on the liver

In recent years, serious concerns about the dangers of kava and the effects on the liver have resulted in regulatory agencies, such as the U.S. Food and Drug Administration and Australia's Therapeutic Goods Administration, banning or restricting the sale of kava and kava products.

26 Feb 2008

Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder

Common antidepressant drugs such as Prozac and Zoloft can be effective treatment options for obsessive compulsive disorder (OCD), according to a new review of studies.

20 Feb 2008

Insomnia patients often denied sleep treatment when they have mental health problems

Patients with insomnia who are diagnosed with accompanying mental health ailments often are not prescribed medication that will help them sleep - which could then make related anxiety or depression worse, new research suggests.

4 Feb 2008

Study suggests Risperidone long-acting injection combined with standard treatment helped delay time to relapse in patients with bipolar disorder

Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those who received standard treatment combined with placebo.

4 Feb 2008

Insomnia News and Research

Latest Insomnia News and Research

Over-the-counter sale of child cough medicine for young children to be banned

Aripiprazole has potential for treating alcohol dependence

Link found between insomnia and depression in young adults

Allergies dramatically impact sufferers' moods and how they feel about themselves

Where nurses are bullied, the quality of patient care declines

Chronic insomnia and its negative consequences for adolescents

Cortisol provide relief for chronic fatigue syndrome and fibromyalgia sufferers

FDA approves PRISTIQ for the treatment of adult patients with major depressive disorder

A similarity in the meaning of sleep quality between insomniacs, normal sleepers

SSRI anti-depressants found to offer little clinical benefit

Effects of Kava on the liver

Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder

Insomnia patients often denied sleep treatment when they have mental health problems

Study suggests Risperidone long-acting injection combined with standard treatment helped delay time to relapse in patients with bipolar disorder

Researchers look at link between inability to express emotions and sleep disturbances

Popular sleeping pill Stilnox in danger of being classed with morphine, narcotics and amphetamines

New Sleep and Breathing Disorders Center at UT Southwestern

Researchers find genetic switch for internal body clock

Premature ejaculation drug Dapoxetine submitted for marketing in approval in Europe

The latest food scare and it's not from China!

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Small solutions for big problems in drug discovery and delivery

Insomnia News and Research

Latest Insomnia News and Research

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Small solutions for big problems in drug discovery and delivery

Newsletters you may be interested in